4
Changes in Ownership
Edgewise Therapeutics, Inc. Filed Acc 0001562180-22-005384
Options or other derivatives
- Director acquired 42,087 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Edris Badreddin Director | 2022-06-24 | Grant or award · Stock Option (Right to Buy) | +42,087 | 42,087 | D | ||
Loading xslF345X03/primarydocument.xml…